Literature DB >> 18458446

Application of nanosized Fe3O4 in anticancer drug carriers with target-orientation and sustained-release properties.

Ben-Lan Lin1, Xiao-Dong Shen, Sheng Cui.   

Abstract

The purpose of this study was to prepare human serum albumin (HSA) microspheres with Fe(3)O(4) magnetic nanoparticles for tumor target therapy. Fe(3)O(4) was obtained by liquid-phase coprecipitation; HSA-coated magnetic particles were attained by solidification at high temperature. The result was that nanosized Fe(3)O(4) is a cubic crystal by XRD and the average size is 18.7 nm; the average size of HSA-coated magnetic particles is 341 nm. Fe(3)O(4) magnetic nanoparticles coated with HSA can be used for targeted-drug carriers with target-orientation and sustained-release properties.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 18458446     DOI： 10.1088/1748-6041/2/2/011

Source DB:  PubMed          Journal:  Biomed Mater        ISSN： 1748-6041            Impact factor:   3.715


  18 in total

Review 1.  Intelligent design of multifunctional lipid-coated nanoparticle platforms for cancer therapy.

Authors:  Srinivas Ramishetti; Leaf Huang
Journal:  Ther Deliv       Date:  2012-12

2.  Manufacture of IRDye800CW-coupled Fe3O4 nanoparticles and their applications in cell labeling and in vivo imaging.

Authors:  Yong Hou; Yingxun Liu; Zhongping Chen; Ning Gu; Jinke Wang
Journal:  J Nanobiotechnology       Date:  2010-10-29       Impact factor: 10.435

3.  Reversal of multidrug resistance by magnetic Fe3O4 nanoparticle copolymerizating daunorubicin and MDR1 shRNA expression vector in leukemia cells.

Authors:  Bao-an Chen; Pei-pei Mao; Jian Cheng; Feng Gao; Guo-hua Xia; Wen-lin Xu; Hui-lin Shen; Jia-hua Ding; Chong Gao; Qian Sun; Wen-ji Chen; Ning-na Chen; Li-jie Liu; Xiao-mao Li; Xue-mei Wang
Journal:  Int J Nanomedicine       Date:  2010-08-09

4.  Magnetic Fe₃O₄ nanoparticles and chemotherapy agents interact synergistically to induce apoptosis in lymphoma cells.

Authors:  Hongmei Jing; Jing Wang; Ping Yang; Xiaoyan Ke; Guohua Xia; Baoan Chen
Journal:  Int J Nanomedicine       Date:  2010-11-19

Review 5.  Inorganic-organic hybrid nanomaterials for therapeutic and diagnostic imaging applications.

Authors:  Juan L Vivero-Escoto; Yu-Tzu Huang
Journal:  Int J Mol Sci       Date:  2011-06-10       Impact factor: 5.923

6.  Magnetic nanoparticle of Fe3O4 and 5-bromotetrandrin interact synergistically to induce apoptosis by daunorubicin in leukemia cells.

Authors:  Baoan Chen; Jian Cheng; Mingfang Shen; Feng Gao; Wenlin Xu; Huilin Shen; Jiahua Ding; Chong Gao; Qian Sun; Xinchen Sun; Hongyan Cheng; Guohong Li; Wenji Chen; Ningna Chen; Lijie Liu; Xiaomao Li; Xuemei Wang
Journal:  Int J Nanomedicine       Date:  2009-04-01

7.  Synergistic effect of magnetic nanoparticles of Fe(3)O(4) with gambogic acid on apoptosis of K562 leukemia cells.

Authors:  Baoan Chen; Yiqiong Liang; Weiwei Wu; Jian Cheng; Guohua Xia; Feng Gao; Jiahua Ding; Chong Gao; Zeye Shao; Guohong Li; Wenji Chen; Wenlin Xu; Xinchen Sun; Lijie Liu; Xiaomao Li; Xuemei Wang
Journal:  Int J Nanomedicine       Date:  2009

8.  Biogenic green synthesis of monodispersed gum kondagogu (Cochlospermum gossypium) iron nanocomposite material and its application in germination and growth of mung bean (Vigna radiata) as a plant model.

Authors:  Dugyala Raju; Urmil J Mehta; Sashidhar Rao Beedu
Journal:  IET Nanobiotechnol       Date:  2016-06       Impact factor: 1.847

9.  Functionalisation of Fe3O4 nanoparticles by 2-((pyrazol-4-yl) methylene) hydrazinecarbothioamide enhances the apoptosis of human breast cancer MCF-7 cells.

Authors:  Mohammad Reza Izadpanah; Ali Salehzadeh; Mohammad Zaefizadeh; Mohammad Nikpasand
Journal:  IET Nanobiotechnol       Date:  2020-08       Impact factor: 1.847

10.  Acute phase pulmonary responses to a single intratracheal spray instillation of magnetite (fe(3)o(4)) nanoparticles in Fischer 344 rats.

Authors:  Yukie Tada; Norio Yano; Hiroshi Takahashi; Katsuhiro Yuzawa; Hiroshi Ando; Yoshikazu Kubo; Akemichi Nagasawa; Akio Ogata; Dai Nakae
Journal:  J Toxicol Pathol       Date:  2012-12-20       Impact factor: 1.628
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.